During the corresponding time, Precision Optics Corporation Inc recorded a revenue increase by 41.95 % year on year, sequentially revenue grew by 0.76 %. While revenue at the Precision Optics Corporation Inc 's corporate clients
Precision Optics Inc's Comment on Sales, Marketing and Customers
The company designs and manufactures ultra-high precision endoscopes, microprecision lenses, assemblies, and complete medical devices for minimally invasive surgical procedures. It also serves the Defense and Aerospace markets, including satellite network communications applications. The business operates in four segments: systems manufacturing, engineering and product development, Ross Optical components and assemblies, and a micro-optics laboratory. Systems manufacturing supports both medical device and advanced aerospace customers by providing complex optical components and assemblies. Ross Optical Industries supplies custom optical components and assemblies for military, defense, medical, and various industrial applications. The company acquired Lighthouse Imaging, LLC to enhance its electrical engineering capabilities for medical visualization devices, integrating these operations under the POC brand. In fiscal year 2026, 72% of revenue came from systems manufacturing, 11% from engineering services for medical device optical assemblies, 15% from Ross Optical, and 2% from the micro-optics laboratory. In fiscal year 2025, revenue distribution was 43% from systems manufacturing, 26% from engineering services, and 20% from Ross Optical. Customers and markets mentioned include Anania & Associates Investment Company, LLC, Lighthouse Imaging, LLC, POC, Ross Optical Industries, and Ross Optical Industries, Inc.
Precision Optics Inc’s Comment on Sales, Marketing and Customers
The company designs and manufactures ultra-high precision endoscopes, microprecision lenses, assemblies, and complete medical devices for minimally invasive surgical procedures. It also serves the Defense and Aerospace markets, including satellite network communications applications. The business operates in four segments: systems manufacturing, engineering and product development, Ross Optical components and assemblies, and a micro-optics laboratory. Systems manufacturing supports both medical device and advanced aerospace customers by providing complex optical components and assemblies. Ross Optical Industries supplies custom optical components and assemblies for military, defense, medical, and various industrial applications. The company acquired Lighthouse Imaging, LLC to enhance its electrical engineering capabilities for medical visualization devices, integrating these operations under the POC brand. In fiscal year 2026, 72% of revenue came from systems manufacturing, 11% from engineering services for medical device optical assemblies, 15% from Ross Optical, and 2% from the micro-optics laboratory. In fiscal year 2025, revenue distribution was 43% from systems manufacturing, 26% from engineering services, and 20% from Ross Optical. Customers and markets mentioned include Anania & Associates Investment Company, LLC, Lighthouse Imaging, LLC, POC, Ross Optical Industries, and Ross Optical Industries, Inc.
Sources:
Precision Optics Corporation Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Precision Optics Corporation Inc’s corporate clients.
For your research, we’ve provided 9 tables on Precision Optics Corporation Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
39.59 %